HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wild-type cutoff for Apramycin against Escherichia coli.

AbstractBACKGROUND:
Apramycin is used exclusively for the treatment of Escherichia coli (E.coli) infections in swine around the world since the early 1980s. Recently, many research papers have demonstrated that apramycin has significant in vitro activity against multidrug-resistant E.coli isolated in hospitals. Therefore, ensuring the proper use of apramycin in veterinary clinics is of great significance of public health. The objectives of this study were to develop a wild-type cutoff for apramycin against E.coli using a statistical method recommended by Clinical and Laboratory Standards Institute (CLSI) and to investigate the prevalence of resistance genes that confer resistance to apramycin in E. coli.
RESULTS:
Apramycin susceptibility testing of 1230 E.coli clinical isolates from swine were determinded by broth microdilution testing according to the CLSI document M07-A9. A total number of 310 E.coli strains from different minimum inhibitory concentration (MIC) subsets (0.5-256 μg/mL) were selected for the detection of resistance genes (aac(3)-IV; npmA; apmA) in E. coli by PCR. The percentage of E. coli isolates at each MIC (0.5, 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL) was 0.08, 0.08, 0.16, 2.93, 31.14, 38.86, 12.85, 2.03, 1.46, and 10.41%. The MIC50 and MIC90 were 16 and 64 μg/mL. All the 310 E.coli isolates were negative for npmA and apmA gene, and only the aac(3)-IV gene was detected in this study.
CONCLUSIONS:
The wild-type cutoff for apramycin against E.coli was defined as 32 μg/mL. The prevelance of aac(3)-IV gene mainly concentrated in these MIC subsets 'MIC ≥ 64 μg/ mL', which indicates that the wild-type cutoff established in our study is reliable. The wild-type cutoff offers interpretion criteria of apramycin susceptibility testing of E.coli.
AuthorsYuqi Yang, Tianshi Xiao, Jiarui Li, Ping Cheng, Fulei Li, Hongxiao Yu, Ruimeng Liu, Ishfaq Muhammad, Xiuying Zhang
JournalBMC veterinary research (BMC Vet Res) Vol. 16 Issue 1 Pg. 309 (Aug 26 2020) ISSN: 1746-6148 [Electronic] England
PMID32847547 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Nebramycin
  • apramycin
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Drug Resistance, Bacterial (genetics)
  • Escherichia coli (drug effects, genetics)
  • Escherichia coli Infections (drug therapy, veterinary)
  • Microbial Sensitivity Tests (veterinary)
  • Nebramycin (analogs & derivatives, pharmacology)
  • Swine
  • Swine Diseases (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: